Synektik Spólka Akcyjna (SNT.WA)
PLN 204.0
(0.74%)
PLN 204.0
(0.74%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 107.81 Million PLN | 58.88% |
| 2023 | 67.86 Million PLN | 882.72% |
| 2022 | 7.03 Million PLN | -37.08% |
| 2021 | 11.18 Million PLN | -7.02% |
| 2020 | 12.03 Million PLN | -5.38% |
| 2019 | 12.71 Million PLN | 9.32% |
| 2018 | 11.63 Million PLN | 225.39% |
| 2017 | 3.57 Million PLN | 67.97% |
| 2016 | 2.12 Million PLN | 473.86% |
| 2015 | -569.22 Thousand PLN | -110.54% |
| 2014 | 5.39 Million PLN | -50.82% |
| 2013 | 10.97 Million PLN | 6295.13% |
| 2012 | 171.67 Thousand PLN | 146.48% |
| 2011 | -369.38 Thousand PLN | -116.27% |
| 2010 | 2.26 Million PLN | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 45.47 Million PLN | 87.52% |
| 2024 Q3 | 20.55 Million PLN | 21.68% |
| 2024 Q2 | 16.89 Million PLN | -62.86% |
| 2023 Q2 | 4.57 Million PLN | -81.4% |
| 2023 Q4 | 24.25 Million PLN | 42.36% |
| 2023 FY | 69.17 Million PLN | 882.72% |
| 2023 Q3 | 17.03 Million PLN | 272.0% |
| 2023 Q1 | 24.62 Million PLN | 1289.61% |
| 2022 Q2 | 7.4 Million PLN | 251.94% |
| 2022 Q4 | 1.77 Million PLN | -18.98% |
| 2022 FY | 7.03 Million PLN | -37.08% |
| 2022 Q1 | 2.1 Million PLN | -54.42% |
| 2022 Q3 | 2.18 Million PLN | -70.48% |
| 2021 Q3 | -517.15 Thousand PLN | -118.67% |
| 2021 Q2 | 2.77 Million PLN | -35.8% |
| 2021 Q1 | 4.31 Million PLN | 11.8% |
| 2021 FY | 11.18 Million PLN | -7.02% |
| 2021 Q4 | 4.61 Million PLN | 993.05% |
| 2020 FY | 12.03 Million PLN | -5.38% |
| 2020 Q4 | 3.86 Million PLN | 157.27% |
| 2020 Q1 | 3.28 Million PLN | 599.88% |
| 2020 Q2 | 3.38 Million PLN | 3.02% |
| 2020 Q3 | 1.5 Million PLN | -55.68% |
| 2019 Q1 | 10.8 Million PLN | 697.12% |
| 2019 FY | 12.71 Million PLN | 9.32% |
| 2019 Q4 | 469.48 Thousand PLN | 125.05% |
| 2019 Q3 | 208.61 Thousand PLN | -83.03% |
| 2019 Q2 | 1.22 Million PLN | -88.62% |
| 2018 Q3 | 1.65 Million PLN | -77.8% |
| 2018 FY | 11.63 Million PLN | 225.39% |
| 2018 Q1 | 4.04 Million PLN | 517.89% |
| 2018 Q2 | 7.44 Million PLN | 84.21% |
| 2018 Q4 | 1.35 Million PLN | -18.02% |
| 2017 FY | 3.57 Million PLN | 67.97% |
| 2017 Q1 | 1.12 Million PLN | 81.33% |
| 2017 Q2 | 240.98 Thousand PLN | -78.55% |
| 2017 Q3 | 496.89 Thousand PLN | 106.2% |
| 2017 Q4 | 654.48 Thousand PLN | 31.72% |
| 2016 Q1 | 685.18 Thousand PLN | -68.66% |
| 2016 Q4 | 619.56 Thousand PLN | 77.42% |
| 2016 Q3 | 349.2 Thousand PLN | 873.25% |
| 2016 Q2 | 35.88 Thousand PLN | -94.76% |
| 2016 FY | 2.12 Million PLN | 473.86% |
| 2015 Q1 | 2.74 Million PLN | 116.18% |
| 2015 FY | -569.22 Thousand PLN | -110.54% |
| 2015 Q2 | -814.05 Thousand PLN | -129.63% |
| 2015 Q4 | 2.18 Million PLN | 183.24% |
| 2015 Q3 | -2.62 Million PLN | -222.7% |
| 2014 Q2 | 267.88 Thousand PLN | -95.59% |
| 2014 Q1 | 6.07 Million PLN | 79.28% |
| 2014 Q3 | 531.72 Thousand PLN | 98.49% |
| 2014 Q4 | 1.27 Million PLN | 139.01% |
| 2014 FY | 5.39 Million PLN | -50.82% |
| 2013 Q2 | 591.6 Thousand PLN | -81.17% |
| 2013 Q4 | 3.38 Million PLN | 263.88% |
| 2013 FY | 10.97 Million PLN | 6295.13% |
| 2013 Q3 | 930.55 Thousand PLN | 57.29% |
| 2013 Q1 | 3.14 Million PLN | 1281.15% |
| 2012 Q3 | -670.78 Thousand PLN | 67.02% |
| 2012 Q4 | -266.06 Thousand PLN | 60.34% |
| 2012 Q2 | -2.03 Million PLN | 0.0% |
| 2012 FY | 171.67 Thousand PLN | 146.48% |
| 2011 FY | -369.38 Thousand PLN | -116.27% |
| 2010 FY | 2.26 Million PLN | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Adiuvo Investments S.A. | -5.07 Million PLN | 2225.749% |
| Genomtec S.A. | -8.72 Million PLN | 1335.453% |
| Medinice S.A. | -5.77 Million PLN | 1965.686% |
| Medicalgorithmics S.A. | 433 Thousand PLN | -24800.224% |